Press "Enter" to skip to content

New patent for Leo Labs drug PICATO

0

Annual Drug Patent Expirations for PICATO
Annual Drug Patent Expirations for PICATO

Picato is a drug marketed by Leo Labs
and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.

This drug has forty-six patent family members in twenty-four countries.

The generic ingredient in PICATO is ingenol mebutate. One supplier is listed for this compound. Additional details are available on the ingenol mebutate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!